Guard Therapeutics International AB (5LH0) Income Statement
Guard Therapeutics International AB Income Statement
Last quarter (Q1 2026), Guard Therapeutics International AB's total revenue was $0.00. In Q1, Guard Therapeutics International AB's net income was $-6.35M. See Guard Therapeutics International AB’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | |
| $ 0.00 | $ 0.00 | $ -15.00K | $ -15.00K | $ -15.00K | |
| $ 107.74M | $ 99.91M | $ 115.07M | $ 113.63M | $ 81.28M | |
| Depreciation and Amortization | $ 0.00 | $ 15.00K | $ 15.00K | $ 15.00K | $ 15.00K |
| $ -107.74M | $ -100.23M | $ -114.91M | $ -112.82M | $ -82.01M | |
| $ -107.74M | $ -99.91M | $ -115.07M | $ -114.92M | $ -81.90M | |
| $ -1.11M | $ 3.84M | $ 1.75M | $ 2.08M | $ -130.00K | |
| $ -108.85M | $ -96.07M | $ -113.32M | $ -112.84M | $ -82.03M | |
| $ -108.85M | $ -96.07M | $ -113.32M | $ -110.76M | $ -82.16M | |
| Per Share Metrics | |||||
| Basic EPS | $ -6.04 | $ -8.62 | $ -11.26 | $ -15.72 | $ -0.74 |
| Diluted EPS | $ -6.04 | $ -8.62 | $ -11.26 | $ -15.72 | $ -0.74 |
| Weighted Average Shares Outstanding | 18.03M | 11.15M | 10.06M | 7.05M | 110.30M |
| Weighted Average Shares Outstanding (Diluted) | 18.03M | 11.15M | 10.06M | 7.05M | 110.30M |
Currency in SEK
